Menopause supplement listings: tablet share by market (October 2026)
October 31, 2026 | by supersuper

Direct answer: In three marketplaces scanned on 30 October 2026, menopause listings returned 76,450 demand units. Tablets led in each market: 90% in the US, 84% in Great Britain and 100% in Australia.
What the October 2026 scan covers
The scan reads menopause supplement listings on three online marketplaces, one per market, dated 30 October 2026. The figures are approximate marketplace signals, not audited sales.
| Market (scan 30 October 2026) | Demand units | Tablet share |
|---|---|---|
| United States | 68,100 | 90% |
| Great Britain | 8,200 | 84% |
| Australia | 150 | 100% |
The three markets total 76,450 units, and most of them sit in the United States. The Australian count of 150 units is too small to read as a trend.
Format mix in each market
| Market | Format share in the scan |
|---|---|
| United States | Tablet 90%, capsule 8%, gummy 2% |
| Great Britain | Tablet 84%, gummy 11%, capsule 5% |
| Australia | Tablet 100% |
Tablets are the leading format in all three markets. The chewable tablet is Bionutricia’s in-house tablet format. Capsules and gummies are shown because they are what the market sells. Neither is a Bionutricia format.
Ingredients named in the listings
The counts are the number of listings in each market’s top-ingredient rows that name the ingredient. They describe what listings contain.
- United States: black cohosh (4), ashwagandha (2), DIM (2), herbal blend (2), probiotics (2).
- Great Britain: red clover (3), sage leaf (3), ashwagandha (2), vitamins (2), black cohosh root extract (1).
- Australia: red clover (3), evening primrose (2), black cohosh (1), bioperine (1).
Red clover appears in 3 listings in Great Britain and 3 listings in Australia.
What the format shares mean for a brand owner
| Format | Route at Bionutricia | Share in the scan |
|---|---|---|
| Chewable tablet | In-house | Recorded as tablet, not split by type: US 90%, Great Britain 84%, Australia 100% |
| Capsule | Not a Bionutricia format | US 8%, Great Britain 5% |
| Gummy | Not a Bionutricia format | US 2%, Great Britain 11% |
Timeline and minimum order
Set up a meeting with our nutrition specialist to decide minimum order, lead time, fill range, pack size and packaging for your product.
Frequently asked questions
Which format leads menopause listings in the scan?
Tablets lead in all three markets: 90% in the United States, 84% in Great Britain and 100% in Australia. The Australian figure rests on 150 units.
Manufacturing a chewable tablet under your own brand
The chewable tablet is the in-house tablet format. Bionutricia’s OEM capability and certifications are set out in the US powder sachet supplements.
Send us your product brief
Tell us the product concept, the format (chewable tablet), the target market, the quantity per run and the launch date. You can send the brief through our enquiry page or request a quotation at our quotation page. You can also email ng@bio-nutricia.com or WhatsApp +60 16-661 8510.
Article by Ts. Ng Kuak Ping. Last updated: 30 October 2026.
Related reading: chewable tablet versus powder sachet, US powder sachet supplements.
RELATED POSTS
View all
